Estimation of amyloid distribution by [18f]flutemetamol pet predicts the neuropathological phase of amyloid β-protein deposition

HIGHLIGHTS

• who: Dietmar Rudolf Thal from the of Neurosciences‑Laboratory Centre for Molecular and Translational Medicine, University Research Institute, Sun City, AZ, USA have published the research work: Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition, in the Journal: (JOURNAL)
• what: This study reports a novel ­[18F]flutemetamol amyloid PETbased method to estimate the anatomical distribution of Aβ-pathology in_vivo corresponding to the pathologically assessed Aβ-phases (Fig 2).
• how: For determination of the PET-Aβ stages the authors used the majority reads.
• future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.